<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01959867</url>
  </required_header>
  <id_info>
    <org_study_id>TEI-BR-001</org_study_id>
    <nct_id>NCT01959867</nct_id>
  </id_info>
  <brief_title>SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy</brief_title>
  <official_title>Clinical Study Comparing Two-Stage Breast Reconstruction Following Mastectomy With and Without the Use of SurgiMend® PRS Fetal Bovine Collagen Matrix in Patients With Pre-Mastectomy Radiation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Integra LifeSciences Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Integra LifeSciences Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective clinical study comparing two-stage breast reconstruction following
      mastectomy with and without the use of SurgiMend® PRS fetal bovine collagen matrix in
      patients with pre-mastectomy radiation therapy.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Capsular Contracture Rate</measure>
    <time_frame>12 months Post-Exchange</time_frame>
    <description>Capsular Contracture Rate (Baker III/IV): Reduction from control through 12 months after expander-to-permanent implant exchange</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Breast Q</measure>
    <time_frame>12 months Post-Exchange</time_frame>
    <description>No decrease in overall patient satisfaction from control as measured by the BREAST-Q Reconstruction Module Patient Satisfaction with Breasts survey, all questions a-p.
Increase in patient satisfaction from control as measured by the BREAST-Q Reconstruction Module Patient Satisfaction with Breasts survey, questions related to capsular contracture.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>No. Capsule Procedures</measure>
    <time_frame>12 months Post-Exchange</time_frame>
    <description>Number of capsule procedures performed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cosmetic Assessment</measure>
    <time_frame>12 months Post-Exchange</time_frame>
    <description>Patient: (BREAST-Q Reconstruction Module) Surgeon: (panel review of standard photographs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Completion</measure>
    <time_frame>12 months Post-Exchange</time_frame>
    <description>Time to Completion (expand-to-implant exchange)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of OR procedures</measure>
    <time_frame>12 month follow-up visit</time_frame>
    <description>Procedural Attributes: Total number of OR procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of visits</measure>
    <time_frame>12 month follow up visit</time_frame>
    <description>Procedural Attributes: Total number of (&quot;in office&quot; and OR procedures)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>SurgiMend® PRS (ADM)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects enrolled in to this cohort will receive SurgiMend® PRS (ADM) product during the first stage of the reconstruction (expander insertion).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects enrolled in to this cohort will not receive an acellular dermal matrix (ADM) product during the first stage of the reconstruction (expander insertion).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SurgiMend® PRS</intervention_name>
    <description>Subjects enrolled in to this cohort will receive SurgiMend® PRS (ADM) product during the first stage of the reconstruction (expander insertion).</description>
    <arm_group_label>SurgiMend® PRS (ADM)</arm_group_label>
    <other_name>ADM, acellular dermal matrix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Intervention</intervention_name>
    <description>Subjects enrolled in to this cohort will not receive an acellular dermal matrix (ADM) product during the first stage of the reconstruction (expander insertion).</description>
    <arm_group_label>No Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is at least 18 years of age

          -  Patient is female

          -  Patient is undergoing immediate, two-stage breast reconstruction following mastectomy
             with or without the use of SurgiMend® PRS

          -  Patient has previously undergone pre-mastectomy XRT for breast cancer, with lumpectomy
             or partial mastectomy, with the previously irradiated breast now being reconstructed
             (with or without contralateral mastectomy &amp; reconstruction)

          -  Patient utilized a textured expander only

          -  Patient utilized a smooth gel permanent implant only

          -  Patient has agreed and is able to comply with the study follow-up requirements

          -  Patient or guardian has provided consent for participation

        Exclusion Criteria:

          -  Patient is undergoing single-stage breast reconstruction

          -  Patient is undergoing a delayed reconstruction

          -  Patient is undergoing reconstruction using a smooth tissue expander, textured gel
             breast implant or any saline breast implant.

          -  Patient is undergoing planned reconstruction using autologous tissue

          -  Patient has a known hypersensitivity to collagen or bovine derived materials

          -  Patient is currently pregnant, nursing, or planning a pregnancy during the course of
             the study

          -  Patient who has had pre-mastectomy XRT bilaterally for breast cancer (either at the
             same time or separated in time)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2013</study_first_submitted>
  <study_first_submitted_qc>October 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2013</study_first_posted>
  <last_update_submitted>January 6, 2017</last_update_submitted>
  <last_update_submitted_qc>January 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mastectomy</keyword>
  <keyword>breast reconstruction</keyword>
  <keyword>bovine</keyword>
  <keyword>ADM</keyword>
  <keyword>breast cancer</keyword>
  <keyword>breast implants</keyword>
  <keyword>breast expanders</keyword>
  <keyword>radiation therapy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

